Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer.

Han Gyul YoonDongryul OhYong Chan AhnJae Myoung NohHongryull PyoWon Kyung ChoYun Mi SongMinsu ParkNa Young HwangJong-Mu SunHong Kwan KimJae Ill ZoYoung Mog Shim

Published in: Cancers (2020)

Excessive muscle loss rather than pre- and post-RT sarcopenia was a significant prognostic factor for OS and RFS, and it was also related to nutritional and inflammatory markers.

Keyphrases

skeletal muscle
prognostic factors
rectal cancer
locally advanced
insulin resistance
lymph node
weight gain
radiation therapy
type diabetes
body mass index
adipose tissue
physical activity
community dwelling
weight loss